TwinBeech Capital’s Meridian Bioscience Inc VIVO Stock Holding History

TwinBeech Capital’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,362	Closed	-$269K	–	779
2022 Q1	$269K	Buy	+10,362	New	+$246K	0.01%	438
2021 Q4	–	Sell	-39,557	Closed	-$761K	–	881
2021 Q3	$761K	Buy	+39,557	New	+$789K	0.05%	366
2021 Q2	–	Sell	-9,600	Closed	-$252K	–	711
2021 Q1	$252K	Buy	+9,600	New	+$228K	0.04%	402
2020 Q4	–	Sell	-26,906	Closed	-$457K	–	672
2020 Q3	$457K	Buy	+26,906	New	+$523K	0.1%	279

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

TwinBeech Capital's VIVO Position: Q2 2022 in Review

TwinBeech Capital sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 10,362 shares — an estimated $269K sold.

TwinBeech Capital first reported a position in VIVO in Q3 2020 and held it in 4 quarters. The position peaked at $761K in Q3 2021. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

TwinBeech Capital reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
TwinBeech Capital sold 10,362 Meridian Bioscience Inc shares in Q2 2022, an estimated $269K.
TwinBeech Capital first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 4 quarters.
TwinBeech Capital's Meridian Bioscience Inc position peaked at $761K in Q3 2021.
216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on TwinBeech Capital's 13F filing for Q2 2022, filed 15 Aug 2022.